Episode 9: Targeting the Microbiome
Update: 2015-12-02
Description
In this episode we're looking at how to make therapies that target our immune system more effective.
Could it be as simple as changing the composition of the bacteria in the gut, the intestinal microbiome that contains a gazillion bugs?
Dr Tom Gajewski (University of Chicago), pictured, describes research from his lab that shows the gut microbiome may impact the efficacy of checkpoint inhibitors.
You'll also hear from Dr Marcel van den Brink (MSKCC) on how changing the composition of the bacteria in the gut may reduce Graft versus Host Disease (GvHD).
There's additional information on NovelTargets.Com
This episode of the podcast is sponsored by Genentech.
Copyright © Blue Ice Publishing LLC, 2015. All Rights Reserved.
Could it be as simple as changing the composition of the bacteria in the gut, the intestinal microbiome that contains a gazillion bugs?
Dr Tom Gajewski (University of Chicago), pictured, describes research from his lab that shows the gut microbiome may impact the efficacy of checkpoint inhibitors.
You'll also hear from Dr Marcel van den Brink (MSKCC) on how changing the composition of the bacteria in the gut may reduce Graft versus Host Disease (GvHD).
There's additional information on NovelTargets.Com
This episode of the podcast is sponsored by Genentech.
Copyright © Blue Ice Publishing LLC, 2015. All Rights Reserved.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
